RxDoctor Payments DataLook up a doctor →

Phillip Sasso, MD

Pain Management · Abington, PANPI 1831191089

Payments from drug & device makers

$49,621in general payments, 2019–2025

Across 1,387 payments — averaging $35.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Foundation Fusion Solutions, LLC$18K
  • Abbott$15K
  • Boston Scientific$4K
  • Vertos Medical, Inc.$3K
  • Collegium Pharmaceutical, Inc.$2K
  • AbbVie$965
  • plus $7K from 54 others

What the payments were for

  • Consulting fees$1000%
  • Travel & lodging$1,6685%
  • Food & beverage$29,71494%
  • Education$400%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Foundation Fusion Solutions, LLC19$18,417
Abbott548$14,701
Boston Scientific188$3,918
Vertos Medical, Inc.140$2,694
Collegium Pharmaceutical, Inc.120$2,015
AbbVie(2 entities)49$965
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC54$739
Scilex Pharmaceuticals Inc.32$729
Medtronic(2 entities)19$516
IBSA Pharma Inc.19$400
Valinor Pharma, LLC19$339
Teva Pharmaceuticals USA, Inc.19$297
Pfizer13$279
Vertex9$275
Averitas Pharma Inc.13$269
Nevro Corp.9$233
Spinal Simplicity, LLC3$217
Lilly USA, LLC9$167
Stryker3$167
Painteq LLC5$149
Biohaven Pharmaceutical Holding Company Ltd.7$146
Redhill Biopharma Inc.7$114
Lundbeck LLC4$105
Zimmer Biomet2$101
Comsort, Inc1$100
E.r. Squibb & Sons, L.L.C.1$99
Protega Pharmaceutials Inc4$94
GRT US Holding, Inc.5$88
Curonix LLC2$85
Vertiflex, Inc.2$82
Forte Bio-pharma LLC2$76
Axsome Therapeutics, Inc.4$69
Kowa Pharmaceuticals America, Inc.5$66
Fidia Pharma USA Inc.3$64
Stimwave Technologies Incorporated4$61
Amneal Pharmaceuticals LLC3$60
Almatica Pharma LLC3$57
Azurity Pharmaceuticals, Inc.3$48
Amgen(2 entities)3$47
Currax Pharmaceuticals LLC3$44
Avanos Medical1$43
Trevena, Inc.2$37
Biohaven Pharmaceuticals, Inc.2$37
Radius Health, Inc.2$35
Bioventus LLC1$34
Virtus Pharmaceuticals LLC2$30
Supernus Pharmaceuticals, Inc.2$29
Globus Medical1$29
Arbor Pharmaceuticals, Inc.2$27
Si-bone, Inc.1$27
Takeda Pharmaceuticals U.S.A., Inc.3$27
Neurocrine Biosciences, Inc.1$24
Nalu Medical, Inc.1$22
Pacira Pharmaceuticals Incorporated1$21
Relievant Medsystems, Inc.1$20
Indivior Inc.1$18
Acelrx Pharmaceuticals, Inc.1$17
Siemens Medical Solutions USA, Inc.1$15
Merck1$14
Orexo US, Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few pain management providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$1,752,101
Medicare patients
1,627
Services billed
38,599

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl159$190,017
Xtampza ErOxycodone Myristate157$80,146
Oxycodone Hcl1,809$37,731
NucyntaTapentadol Hcl24$33,396
Oxymorphone Hcl ErOxymorphone Hcl12$31,114
MovantikNaloxegol Oxalate54$30,412
ZtlidoLidocaine35$25,982
Nurtec OdtRimegepant Sulfate18$25,140
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl131$23,407
BelbucaBuprenorphine Hcl32$23,041
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen743$20,014
Gabapentin1,375$16,217
Morphine Sulfate ErMorphine Sulfate467$11,875
LyricaPregabalin13$10,792
Nucynta ErTapentadol Hcl11$10,699

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Nucynta, Belbuca, Nucynta Er$2,015$147,282224 claims
PfizerNurtec Odt, Lyrica$279$35,93231 claims
Redhill Biopharma Inc.Movantik$114$30,41254 claims
Scilex Pharmaceuticals Inc.Ztlido$729$25,98235 claims
AbbVieSavella$965$6,46412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few pain management providers in Pennsylvaniaon file to place this against a meaningful peer group, so we don't.

Other pain management in Abington

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →